You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Retinitis

Showing 26 - 50 of 426
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess the Reliability and Validity of the MLYMT

Recruiting
  • Retinitis Pigmentosa
  • Retinal Dystrophy
  • Observational
  • Beverly Hills, California
  • +6 more
Apr 18, 2023

X-Linked Retinitis Pigmentosa

Completed
  • X-Linked Retinitis Pigmentosa
  • Other: Assessments
  • Phoenix, Arizona
  • +21 more
Jan 17, 2023

Objective Perimetry Using Chromatic Multifocal Pupillometer

Recruiting
  • Retinal Dystrophies
  • +2 more
    • Tel HaShomer, Israel
      Sheba Medical Center
    Jan 15, 2023

    Retinitis Pigmentosa Trial (Subtenon injection of Wharton jelly derived mesenchymal stem cells, Subtenon injection of Wharton

    Recruiting
    • Retinitis Pigmentosa
    • Subtenon injection of Wharton jelly derived mesenchymal stem cells
    • +2 more
    • Kayseri, Turkey
      Erciyes University, Faculty of Medicine
    Sep 5, 2022

    Study of BEST1 Vitelliform Macular Dystrophy

    Recruiting
    • Best Vitelliform Macular Dystrophy
    • Retinitis Pigmentosa
    • Natural History Study
    • New York, New York
    • +2 more
    Mar 30, 2023

    Retinitis Pigmentosa Trial in Baltimore (N-Acetyl Cysteine (NAC))

    Completed
    • Retinitis Pigmentosa
    • N-Acetyl Cysteine (NAC)
    • Baltimore, Maryland
      Wilmer Eye Institute, Johns Hopkins
    Sep 15, 2022

    Study in Subjects Who Received vMCO-I Administered Via

    Enrolling by invitation
    • Retinitis Pigmentosa
    • +2 more
    • Gene Therapy product:vMCO-I
    • Cuttack, Odisha, India
      JPM Rotary Club of Cuttack Eye Hospital and Research Institute
    Jun 26, 2023

    Non-syndromic Retinitis Pigmentosa Trial in Pittsburgh, Paris, London (Gene therapy: GS030-DP AND Medical device: GS030-MD)

    Recruiting
    • Non-syndromic Retinitis Pigmentosa
    • Gene therapy: GS030-DP AND Medical device: GS030-MD
    • Pittsburgh, Pennsylvania
    • +2 more
    Jul 25, 2022

    Retinitis Pigmentosa Trial in Pittsburgh, Paris (Ophthalmic examinations, Mobility Test)

    Active, not recruiting
    • Retinitis Pigmentosa
    • Ophthalmic examinations
    • Mobility Test
    • Pittsburgh, Pennsylvania
    • +1 more
    Apr 19, 2022

    Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells)

    Completed
    • Retinitis Pigmentosa
    • human retinal progenitor cells
    • Irvine, California
    • +2 more
    Aug 8, 2022

    X-Linked Retinitis Pigmentosa Trial in United States (4D-125 IVT Injection, Observational)

    Recruiting
    • X-Linked Retinitis Pigmentosa
    • 4D-125 IVT Injection
    • Observational
    • Aurora, Colorado
    • +7 more
    Aug 18, 2022

    Cell Collection to Study Eye Diseases

    Recruiting
    • Retinal Disease
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 23, 2023

      Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for

      Terminated
      Has Results
      • Retinitis Pigmentosa
      • Usher Syndrome Type 2
      • RNA antisense oligonucleotide for intravitreal injection
      • Boston, Massachusetts
      • +6 more
      Dec 12, 2022

      Retinitis Pigmentosa Trial in Stockholm (CPK850)

      Recruiting
      • Retinitis Pigmentosa
      • CPK850
      • Stockholm, Sweden
        Novartis Investigative Site
      May 16, 2022

      Retinitis Pigmentosa Trial in Fort Lauderdale (Electro-acupuncture, Laser Acupuncture, Transcorneal Electrical Stimulation)

      Active, not recruiting
      • Retinitis Pigmentosa
      • Electro-acupuncture
      • +5 more
      • Fort Lauderdale, Florida
        Nova Southeastern University; College of Optometry
      May 6, 2022

      Long Term Follow-Up Gene Therapy Study for XLRP RPGR

      Recruiting
      • X-Linked Retinitis Pigmentosa
      • AAV-RPGR
      • Boston, Massachusetts
      • +3 more
      Dec 5, 2022

      X-Linked Retinitis Pigmentosa Trial in Worldwide (Genetic: AAV5-RPGR 4e11, Genetic: AAV5-RPGR 2e11)

      Recruiting
      • X-Linked Retinitis Pigmentosa
      • Genetic: AAV5-RPGR 4e11
      • Genetic: AAV5-RPGR 2e11
      • Los Angeles, California
      • +9 more
      Aug 16, 2022

      Inherited Retinal Dystrophies Using Whole Genome Sequencing and

      Recruiting
      • Inherited Retinal Dystrophy
      • +2 more
      • whole genome sequencing
      • Rome, Italy
        Istituto Superiore di Sanità-Dpt. Oncology and Molecular Medicin
      Mar 30, 2023

      Retinitis Pigmentosa Trial in Pittsburgh, Paris (SPVN06)

      Not yet recruiting
      • Retinitis Pigmentosa
      • Pittsburgh, Pennsylvania
      • +1 more
      Feb 17, 2023

      Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham

      Active, not recruiting
      • Retinitis Pigmentosa
      • +6 more
      • Gene Therapy Product-vMCO-010
      • Sham Injection
      • Beverly Hills, California
      • +6 more
      Jul 13, 2022

      Usher Syndrome, Retinitis Pigmentosa Trial in Portland, Paris (SAR421869)

      Terminated
      Has Results
      • Usher Syndrome
      • Retinitis Pigmentosa
      • Portland, Oregon
      • +1 more
      Mar 30, 2022

      Clinical Implication of Retinitis Pigmentosa Molecular

      Recruiting
      • Retinitis Pigmentosa
        • Dijon, France
        • +3 more
        Apr 19, 2022

        Retinitis Pigmentosa, Usher Syndrome Type 2, Usher Syndrome Type 3 Trial in San Francisco (NT-501, Sham)

        Completed
        • Retinitis Pigmentosa
        • +2 more
        • San Francisco, California
          University of California, San Francisco
        Apr 14, 2022

        Repository for Inherited Eye Diseases

        Active, not recruiting
        • Retinitis Pigmentosa
        • Inherited Ophthalmic Diseases
          • Bethesda, Maryland
            National Institutes of Health Clinical Center, 9000 Rockville Pi
          Aug 24, 2022

          Retinitis Pigmentosa Trial in Rome (Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP))

          Completed
          • Retinitis Pigmentosa
          • Subretinal injection of umbilical cord blood platelet-rich plasma (CB-PRP)
          • Rome, Italy
            Alfonso Savastano
          Jan 10, 2022